Hepatitis Monthly

Published by: Neoscriber Demo Publisher

Influential Factors of Hepatitis B Virus cccDNA in Peripheral Blood Mononuclear Cells Among HBsAg-Positive Pregnant Females Neonates

Xiao-Hong Shi 1 , Bo Wang 2 , Shu-Ying Feng 2 , Zhen Guo 1 , 3 , Jian Guo 1 , 4 , Xue-Fei Wang 1 , Shu-Zhen Li 1 , Yong-Liang Feng 1 and Su-Ping Wang 1 , *
Authors Information
1 Department of Epidemiology, School of Public Health, Shanxi Medical University, Taiyuan, Shanxi Province, China
2 Department of Obstetrics and Gynaecology, The Third People Hospital of Taiyuan City, Taiyuan, Shanxi Province, China
3 Central laboratory, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan Province, China
4 School of Public Health, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
Article information
  • Hepatitis Monthly: October 2018, 18 (10); e55064
  • Published Online: April 30, 2018
  • Article Type: Research Article
  • Received: June 16, 2017
  • Revised: December 12, 2017
  • Accepted: April 24, 2018
  • DOI: 10.5812/hepatmon.55064

To Cite: Shi X, Wang B, Feng S, Guo Z, Guo J, et al. Influential Factors of Hepatitis B Virus cccDNA in Peripheral Blood Mononuclear Cells Among HBsAg-Positive Pregnant Females Neonates, Hepat Mon. 2018 ; 18(10):e55064. doi: 10.5812/hepatmon.55064.

Copyright © 2018, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30(12):2212-9. doi: 10.1016/j.vaccine.2011.12.116. [PubMed: 22273662].
  • 2. Chen Y, Wang L, Xu Y, Liu X, Li S, Qian Q, et al. Role of maternal viremia and placental infection in hepatitis B virus intrauterine transmission. Microbes Infect. 2013;15(5):409-15. doi: 10.1016/j.micinf.2013.02.008. [PubMed: 23500187].
  • 3. Yu M, Jiang Q, Gu X, Ju L, Ji Y, Wu K, et al. Correlation between vertical transmission of hepatitis B virus and the expression of HBsAg in ovarian follicles and placenta. PLoS One. 2013;8(1). e54246. doi: 10.1371/journal.pone.0054246. [PubMed: 23382883].
  • 4. Bai GQ, Li SH, Yue YF, Shi L. The study on role of peripheral blood mononuclear cell in HBV intrauterine infection. Arch Gynecol Obstet. 2011;283(2):317-21. doi: 10.1007/s00404-010-1366-8. [PubMed: 20107823].
  • 5. Gatta A, Giannini C, Lampertico P, Pontisso P, Quarta S, Zignego AL, et al. Hepatotropic viruses: new insights in pathogenesis and treatment. Clin Exp Rheumatol. 2008;26(1 Suppl 48):S33-8. [PubMed: 18570752].
  • 6. Xu YY, Liu HH, Zhong YW, Liu C, Wang Y, Jia LL, et al. Peripheral blood mononuclear cell traffic plays a crucial role in mother-to-infant transmission of hepatitis B virus. Int J Biol Sci. 2015;11(3):266-73. doi: 10.7150/ijbs.10813. [PubMed: 25678845].
  • 7. Xue SL, Wei JN, Wang B, Shuang JY, Feng LP. Association of placental apoptosis and PBMC transfer with HBsAg of PBMC in neonates. Chin J Public Health. 2015;31:199-201. Chinese.
  • 8. Li XM, Shi MF, Yang YB, Shi ZJ, Hou HY, Shen HM, et al. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World J Gastroenterol. 2004;10(21):3215-7. doi: 10.3748/wjg.v10.i21.3215. [PubMed: 15457579].
  • 9. Zou H, Chen Y, Duan Z, Zhang H, Pan C. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J Viral Hepat. 2012;19(2):e18-25. doi: 10.1111/j.1365-2893.2011.01492.x. [PubMed: 22239517].
  • 10. Addison WR, Walters KA, Wong WW, Wilson JS, Madej D, Jewell LD, et al. Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication. J Virol. 2002;76(12):6356-63. doi: 10.1128/JVI.76.12.6356-6363.2002. [PubMed: 12021368].
  • 11. Singh M, Dicaire A, Wakil AE, Luscombe C, Sacks SL. Quantitation of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) in the liver of HBV-infected patients by LightCycler real-time PCR. J Virol Methods. 2004;118(2):159-67. doi: 10.1016/j.jviromet.2004.02.006. [PubMed: 15081611].
  • 12. Torii N, Hasegawa K, Joh R, Hayashi N. Configuration and replication competence of hepatitis B virus DNA in peripheral blood mononuclear cells from chronic hepatitis B patients and patients who have recovered from acute self-limited hepatitis. Hepatol Res. 2003;25(3):234-43. doi: 10.1016/S1386-6346(02)00275-9. [PubMed: 12697244].
  • 13. Cabrerizo M, Bartolome J, Caramelo C, Barril G, Carreno V. Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases. Hepatology. 2000;32(1):116-23. doi: 10.1053/jhep.2000.8541. [PubMed: 10869298].
  • 14. Shi XH, Wang SP, Li SZ, Xie LJ, Feng LP, Shuang JY. Study on replication status of HBsAg positive pregnant women and newborns. Chin J Public Health. 2004;20(5):513-4. Chinese.
  • 15. Fan JS, Zhuang H, Zhu XJ. Comparative study on the clinical and epidemiological characteristics of HBsAg negative and positive hepatitis B in 6 cities in China. Chin J Prev Med. 1996;30(Suppl):17-9. Chinese.
  • 16. Kock J, Theilmann L, Galle P, Schlicht HJ. Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus. Hepatology. 1996;23(3):405-13. doi: 10.1002/hep.510230303. [PubMed: 8617418].
  • 17. Guo Z, Shi XH, Feng YL, Wang B, Feng LP, Wang SP, et al. Risk factors of HBV intrauterine transmission among HBsAg-positive pregnant women. J Viral Hepat. 2013;20(5):317-21. doi: 10.1111/jvh.12032. [PubMed: 23565613].
  • 18. Shao ZJ, Zhang L, Xu JQ, Xu DZ, Men K, Zhang JX, et al. Mother-to-infant transmission of hepatitis B virus: a Chinese experience. J Med Virol. 2011;83(5):791-5. doi: 10.1002/jmv.22043. [PubMed: 21360547].
  • 19. Chen Y, Sze J, He ML. HBV cccDNA in patients' sera as an indicator for HBV reactivation and an early signal of liver damage. World J Gastroenterol. 2004;10(1):82-5. Chinese. doi: 10.3748/wjg.v10.i1.82. [PubMed: 14695774].
  • 20. Chen L, Wu C, Fan X, Gao J, Yin H, Wang T, et al. Replication and infectivity of hepatitis B virus in HBV-related glomerulonephritis. Int J Infect Dis. 2009;13(3):394-8. doi: 10.1016/j.ijid.2008.08.014. [PubMed: 19036623].
  • 21. Yu MM, Gu XJ, Xia Y, Wang GJ, Kan NY, Wu KH. [Relationship between the expression of HBV DNA, HBV cccDNA in human ovary tissues and the HBV intrauterine infection]. Zhonghua Liu Xing Bing Xue Za Zhi. 2013;34(2):178-82. [PubMed: 23751477].
  • 22. Coffin CS, Mulrooney-Cousins PM, van Marle G, Roberts JP, Michalak TI, Terrault NA. Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy. Liver Transpl. 2011;17(8):955-62. doi: 10.1002/lt.22312. [PubMed: 21462295].
  • 23. Vakili Ghartavol Z, Alavian SM, Amini S, Vahabpour R, Bahramali G, Mostafavi E, et al. Prevalence of occult hepatitis B virus in plasma and peripheral blood mononuclear cell compartments of patients with chronic hepatitis C infection in tehran-iran. Hepat Mon. 2013;13(5). e10134. doi: 10.5812/hepatmon.10134. [PubMed: 23967017].
  • 24. Caruntu FA, Molagic V. CccDNA persistence during natural evolution of chronic VHB infection. Rom J Gastroenterol. 2005;14(4):373-7. [PubMed: 16400354].
  • 25. Badur S, Lazizi Y, Ugurlu M, Perk Y, Ilter O, Aydinli K, et al. Transplacental passage of hepatitis B virus DNA from hepatitis B e antigen-negative mothers and delayed immune response in newborns. J Infect Dis. 1994;169(3):704-6. doi: 10.1093/infdis/169.3.704. [PubMed: 8158060].
  • 26. Abdelhamed AM, Kelley CM, Miller TG, Furman PA, Isom HC. Rebound of hepatitis B virus replication in HepG2 cells after cessation of antiviral treatment. J Virol. 2002;76(16):8148-60. [PubMed: 12134020].
  • 27. Lin CL, Yang HC, Kao JH. Hepatitis B virus: new therapeutic perspectives. Liver Int. 2016;36 Suppl 1:85-92. doi: 10.1111/liv.13003. [PubMed: 26725903].
  • 28. Koniger C, Wingert I, Marsmann M, Rosler C, Beck J, Nassal M. Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses. Proc Natl Acad Sci U S A. 2014;111(40):E4244-53. doi: 10.1073/pnas.1409986111. [PubMed: 25201958].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments